|

Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation

RECRUITINGN/ASponsored by Roswell Park Cancer Institute
Actively Recruiting
PhaseN/A
SponsorRoswell Park Cancer Institute
Started2025-03-14
Est. completion2026-03-14
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

This clinical trial compares the use of virtual reality to standard care for improving symptom management in patients undergoing hematopoietic stem cell transplantation (HSCT). Significant symptoms experienced by hospitalized HSCT patients include, but are not limited to, depression, tiredness, anxiety, drowsiness, lack of appetite, pain, and overall decreased quality of life and well-being. Virtual reality (VR) as an intervention can provide these patients with a much-needed escape from their reality and has proven results in clinical settings as a distraction therapy. VR technology targets the patient's auditory, visual, and physical contact/touch senses, and has been evidenced to improve depression, fatigue, anxiety, appetite, and pain. Virtual reality may improve symptom management in patients undergoing HSCT.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Adult patients (≥ 18 years old) admitted to Roswell Park on 5 North for planned hematopoietic stem cell transplantation (HSCT)
* Must be alert and oriented (Glascow Coma Scale of 15, Nursing Universal Flowsheet) and able to consent to participate in the study
* Expected to be admitted to Roswell Park inpatient unit for ≥ 1 week
* Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Exclusion Criteria:

* Participants with known brain metastases should be excluded from this clinical trial because of their poor prognosis and because they often develop progressive neurologic dysfunction that would confound the evaluation of neurologic and other adverse events
* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
* Pregnant patients
* Incarcerated patients
* Patients who are unwilling or unable to follow protocol requirements
* Individuals that are prone to motion sickness, nausea, dizziness, history of seizure, potential for seizure, history of delirium, at risk for confusion, etc
* Participants with audio and/or visual impairments that would preclude them from using a VR device

Conditions3

CancerHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Locations1 site

Roswell Park Cancer Institute
Buffalo, New York, 14263
Heather Huizinga716-845-5482Heather.Huizinga@RoswellPark.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.